OncoResponse Appoints Robert Lechleider, MD as Chief Medical Officer; Promotes Kamal Puri, PhD to Chief Scientific Officer
SEATTLE, WA / ACCESSWIRE / April 14, 2020 / OncoResponse, a biotechnology company developing human antibodies as product candidates for multiple...